Explore
Validate
Learn500-P161G-100UG
antibody from Invitrogen Antibodies
Targeting: DEFB4A
DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [13]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 500-P161G-100UG - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- beta-2 Defensin Polyclonal Antibody, PeproTech®
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- AA Sequence of recombinant protein: GIGDPVTCLK SGAICHPVFC PRRYKQIGTC GLPGTKCCKK P.
- Concentration
- 0.1-1.0 mg/mL
Submitted references Topical Estrogen Treatment Augments the Vaginal Response to Escherichia coli Flagellin.
Bitter and sweet taste receptors regulate human upper respiratory innate immunity.
Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay.
Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells.
Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skin.
IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression.
UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo.
Development and validation of human psoriatic skin equivalents.
Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.
Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients.
Barrier function, epidermal differentiation, and human beta-defensin 2 expression in tinea corporis.
Quantification of human beta-defensin-2 and -3 in body fluids: application for studies of innate immunity.
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2.
Stanton A, Mowbray C, Lanz M, Brown K, Hilton P, Tyson-Capper A, Pickard RS, Ali ASM, Hall J
Scientific reports 2020 May 21;10(1):8473
Scientific reports 2020 May 21;10(1):8473
Bitter and sweet taste receptors regulate human upper respiratory innate immunity.
Lee RJ, Kofonow JM, Rosen PL, Siebert AP, Chen B, Doghramji L, Xiong G, Adappa ND, Palmer JN, Kennedy DW, Kreindler JL, Margolskee RF, Cohen NA
The Journal of clinical investigation 2014 Mar;124(3):1393-405
The Journal of clinical investigation 2014 Mar;124(3):1393-405
Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay.
Eade CR, Diaz C, Wood MP, Anastos K, Patterson BK, Gupta P, Cole AL, Cole AM
PloS one 2012;7(11):e50106
PloS one 2012;7(11):e50106
Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells.
de Oliveira VL, Keijsers RR, van de Kerkhof PC, Seyger MM, Fasse E, Svensson L, Latta M, Norsgaard H, Labuda T, Hupkens P, van Erp PE, Joosten I, Koenen HJ
PloS one 2012;7(10):e45509
PloS one 2012;7(10):e45509
Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skin.
Bak RO, Stenderup K, Rosada C, Petersen LB, Moldt B, Dagnæs-Hansen F, Jakobsen M, Kamp S, Jensen TG, Dam TN, Mikkelsen JG
BMC dermatology 2011 Feb 27;11:5
BMC dermatology 2011 Feb 27;11:5
IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression.
Johnston A, Xing X, Guzman AM, Riblett M, Loyd CM, Ward NL, Wohn C, Prens EP, Wang F, Maier LE, Kang S, Voorhees JJ, Elder JT, Gudjonsson JE
Journal of immunology (Baltimore, Md. : 1950) 2011 Feb 15;186(4):2613-22
Journal of immunology (Baltimore, Md. : 1950) 2011 Feb 15;186(4):2613-22
UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo.
Gläser R, Navid F, Schuller W, Jantschitsch C, Harder J, Schröder JM, Schwarz A, Schwarz T
The Journal of allergy and clinical immunology 2009 May;123(5):1117-23
The Journal of allergy and clinical immunology 2009 May;123(5):1117-23
Development and validation of human psoriatic skin equivalents.
Tjabringa G, Bergers M, van Rens D, de Boer R, Lamme E, Schalkwijk J
The American journal of pathology 2008 Sep;173(3):815-23
The American journal of pathology 2008 Sep;173(3):815-23
Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.
Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Zaba LC, Cardinale I, Nograles KE, Khatcherian A, Novitskaya I, Carucci JA, Bergman R, Krueger JG
Journal of immunology (Baltimore, Md. : 1950) 2008 Nov 15;181(10):7420-7
Journal of immunology (Baltimore, Md. : 1950) 2008 Nov 15;181(10):7420-7
Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients.
Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D, Kamsteeg M, Verhoosel RM, van Rossum MM, Hiemstra PS, Schalkwijk J
PloS one 2008 Jun 4;3(6):e2301
PloS one 2008 Jun 4;3(6):e2301
Barrier function, epidermal differentiation, and human beta-defensin 2 expression in tinea corporis.
Jensen JM, Pfeiffer S, Akaki T, Schröder JM, Kleine M, Neumann C, Proksch E, Brasch J
The Journal of investigative dermatology 2007 Jul;127(7):1720-7
The Journal of investigative dermatology 2007 Jul;127(7):1720-7
Quantification of human beta-defensin-2 and -3 in body fluids: application for studies of innate immunity.
Ghosh SK, Gerken TA, Schneider KM, Feng Z, McCormick TS, Weinberg A
Clinical chemistry 2007 Apr;53(4):757-65
Clinical chemistry 2007 Apr;53(4):757-65
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2.
Voss E, Wehkamp J, Wehkamp K, Stange EF, Schröder JM, Harder J
The Journal of biological chemistry 2006 Jan 27;281(4):2005-11
The Journal of biological chemistry 2006 Jan 27;281(4):2005-11
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot: To detect Human BD-2 by Western Blot analysis beta-2 Defensin Polyclonal Antibody (Product # 500-P161G-1MG) can be used at a concentration of 0.1- 0.2 µg/mL. Used in conjunction with compatible secondary reagents the detection limit for Recombinant Human BD-2 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot: To detect Human BD-2 by Western Blot analysis beta-2 Defensin Polyclonal Antibody (Product # 500-P161G-1MG) can be used at a concentration of 0.1- 0.2 µg/mL. Used in conjunction with compatible secondary reagents the detection limit for Recombinant Human BD-2 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Sandwich ELISA: To detect Human BD-2 by sandwich ELISA (using 100 µL/well antibody solution) a concentration of 0.5-2.0 µg/mL of beta-2 Defensin Polyclonal Antibody (Product # 500-P161G-1MG) is required. This antigen affinity purified antibody, in conjunction with PeproTech beta-2 Defensin Polyclonal Antibody, Biotin (Product # 500-P161GBT-1MG) as a detection antibody, allows the detection of at least 0.2-0.4 ng/well of Recombinant Human BD-2.
